|
|
||||
|
Cox-2 confusion
Email: Peg Brickley - pegbrickley@hotmail.com News from The Scientist 2003, 4(1):20030324-01 doi:10.1186/20030324-01
|
||||
|
|
||||
|
Debate over the University of Rochester's (UR) claim for royalties from arthritis blockbuster Celebrex continues as UR appeals an early defeat for its patent on cox-2 inhibitors. Though the district court ruling this month against UR sent a chill through academic labs that rely on basic-science patents, attorneys disagree on how relevant the Rochester case will really be for other academic researchers.
|
|
|||||||||
|
|||||||||
|